Fangfang Yang

Papers

Total Citations

H-Index

About

Fangfang Yang is a leading thoracic surgeon whose research focuses on advancing minimally invasive surgical techniques for lung cancer treatment, particularly robotic-assisted thoracoscopic surgery (RATS). Her major contribution lies in optimizing surgical precision and patient outcomes in early-stage non-small cell lung cancer (NSCLC). In her highly cited 2025 study, "Optimizing surgical precision: a comparative study of three-port vs. four-port robotic-assisted lobectomy for NSCLC," Yang systematically compared short-term postoperative outcomes between these two approaches, providing critical evidence that fewer ports can reduce trauma without compromising safety or efficacy. This work has already garnered 2 citations shortly after publication, reflecting its immediate impact on clinical practice. Yang’s research is notable for bridging the gap between technological innovation and practical surgical application, helping to refine robotic lobectomy protocols. Her findings are shaping how thoracic surgeons approach NSCLC resections, emphasizing patient-centered outcomes like reduced pain and faster recovery. As a rising authority in robotic thoracic surgery, Yang continues to drive evidence-based improvements that enhance surgical precision and quality of life for lung cancer patients.